A, S., C, L., A, S., TD, S., & M, S. (2026). Linezolid versus clindamycin for toxin inhibition in severe skin and soft tissue infections: A systematic review and meta-analysis. Infection, 54(2), 877. https://doi.org/10.1007/s15010-025-02722-6
Chicago Style (17th ed.) CitationA, Stropes, Lautenschlager C, Smith A, Steuber TD, and Sperry M. "Linezolid Versus Clindamycin for Toxin Inhibition in Severe Skin and Soft Tissue Infections: A Systematic Review and Meta-analysis." Infection 54, no. 2 (2026): 877. https://doi.org/10.1007/s15010-025-02722-6.
MLA (9th ed.) CitationA, Stropes, et al. "Linezolid Versus Clindamycin for Toxin Inhibition in Severe Skin and Soft Tissue Infections: A Systematic Review and Meta-analysis." Infection, vol. 54, no. 2, 2026, p. 877, https://doi.org/10.1007/s15010-025-02722-6.